Blog
RSS FeedPosted by Michael Wonder on 25 Jul 2024
Kye Pharmaceuticals secures exclusive license, supply and commercialisation agreement with Catalyst Pharmaceuticals for Agamree, a novel treatment for Duchenne muscular dystrophy, in Canada
24 July 2024 - Kye Pharmaceuticals today announced that it has entered into a license, supply and commercialisation agreement with Catalyst ...
Posted by Michael Wonder on 15 Jul 2024
Onco360 selected as a limited distribution specialty pharmacy partner for Rytelo (imetelstat)
12 July 2024 - Onco360 has been selected as a pharmacy partner by Geron Corporation for Rytelo (imetelstat) as a ...
Posted by Michael Wonder on 05 Jul 2024
An online pharmacy pledged to make prescriptions easier. It sent the wrong drugs instead.
4 July 2024 - Elevance’s CarelonRx customers waited weeks for prescriptions or received medications that could have harmed them. ...
Posted by Michael Wonder on 03 Jun 2024
New pharmacy agreement delivers cheaper medicines
3 June 2024 - The Albanese Government and the Pharmacy Guild of Australia have signed the eighth Community Pharmacy Agreement ...
Posted by Michael Wonder on 22 May 2024
Janssen Korea to cease supply of anti-fungal drug Sporanox
22 May 2024 - Janssen Korea will discontinue the supply of its anti-fungal drug Sporanox (itraconazole) solution. ...
Posted by Michael Wonder on 19 May 2024
Doctors say PHARMAC too slow to act over hormone replacement therapy patch shortage
18 May 2024 - The shortage of hormone replacement therapy patches is getting worse, and PHARMAC has been too slow ...
Posted by Michael Wonder on 23 Apr 2024
New recommendations to strengthen supply chains of critical medicines
23 April 2024 - EMA has published a number of recommendations to address vulnerabilities in the production and delivery of medicines ...
Posted by Michael Wonder on 14 Mar 2024
Securing cheaper medicines and improved patient outcomes through 8th Community Pharmacy Agreement
14 March 2024 - The Albanese Government and Pharmacy Guild of Australia have reached a Heads of Agreement for an ...
Posted by Michael Wonder on 03 Mar 2024
Cheaper medicines with twice as many medicines now available for a 60 day prescription
3 March 2024 - The Albanese Government is making medicines cheaper by doubling the number of medicines now available for ...
Posted by Michael Wonder on 24 Feb 2024
Shortage of migraine medication crushing for chronic pain patients
23 February 2024 - A migraine medication shortage has spread across the country, threatening to leave tens of thousands of ...
Posted by Michael Wonder on 13 Dec 2023
First version of the Union list of critical medicines agreed to help avoid potential shortages in the EU
12 December 2023 - The European Commission, the Heads of Medicines Agencies and EMA have published the first version of the ...
Posted by Michael Wonder on 13 Nov 2023
Novo Nordisk to discontinue Levemir insulin in US market
8 November 2023 - Novo Nordisk said on Wednesday it would discontinue its long-acting insulin Levemir in the United States, ...
Posted by Michael Wonder on 04 Nov 2023
Hormone replacement therapy patch shortages are having a big impact on the women who need them
4 November 2023 - Women are being thrust back into the most severe stages of menopause amid long-running national shortages of ...
Posted by Michael Wonder on 03 Nov 2023
Mounjaro (tirzepatide), the first and only single molecule GIP and GLP-1 receptor agonist for the treatment of adults with type 2 diabetes is now available in Canada
2 November 2023 - Mounjaro represents the first new class of diabetes medicines introduced in nearly a decade and is now ...
Posted by Michael Wonder on 30 Oct 2023
Fresh hope over discontinued painkiller but patients fear replacement doses are 'useless'
27 October 2023 - Patients with terminal illnesses and painful chronic conditions have been offered hope thanks to a deal ...